Forum: Decriminalization of cannabis

Current Opinion in Psychiatry

Volumn 21, Issue 2, 2008, Pages 122-126

  Van Den Brink, Wim ^a,b  

^a AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; RECREATIONAL DRUG;

CANNABIS ADDICTION; CRIMINAL LAW; DECRIMINALIZATION; DRUG ABUSE; ENVIRONMENTAL FACTOR; HEALTH CARE POLICY; HEALTH HAZARD; HEREDITY; HUMAN; LAW; LEGAL PROCEDURE; MENTAL HEALTH; PROHIBITION; QUALITY CONTROL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT;

BEHAVIOR, ADDICTIVE; CONSENSUS; CRIME; HUMANS; MARIJUANA ABUSE; RISK FACTORS;

EID: 40349115925     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3282f57e04     Document Type: Review

References (52)

1. Hall W. The recent Australian debate about the prohibition on cannabis use. Addiction 1997; 92:1109-1115.
2. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2002. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2002.
3. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 2002; 2:244-268.
4. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369:1047-1053.
5. Kendler KS, Prescott CA. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 1998; 155:1016-1022.
6. Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000; 57:261-269.
7. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003; 160:687-695.
8. Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med 2004; 34:1227-1237.
9. Compton WM, Thomas YF, Conway KP, Colliver JD. Developments in the epidemiology of drug use and drug use disorders. Am J Psychiatry 2005; 162:1494-1502.
10. Golub A, Johnson BD, Dunlap E. Smoking marijuana in public: the spatial and policy shift in New York City arrests, 1992-2003. Harm Reduct J 2006; 3:22.
11. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006; 101:556-569.
12. Tarter RE, Vanyukov M, Kirisci L, et al. Predictors of marijuana use in adolescents before and after licit drug use: examination of the gateway hypothesis. Am J Psychiatry 2006; 163:2134-2140.
13. Morral AR, McCaffrey DF, Paddock SM. Reassessing the marijuana gateway effect. Addiction 2002; 97:1493-1504.
14. Agrawal A, Neale MC, Prescott CA, Kendler KS. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav Genet 2004; 34:217-228.
15. MacCoun R, Reuter P. Evaluating alternative cannabis regimes. Br J Psychiatry 2001; 178:123-128.
16. Engelsman EL. Dutch policy on the management of drug-related problems. Br J Addict 1989; 84:211-218.
17. Kalant H, Corrigall W, Hall W, Smart R. The health effects of cannabis. Toronto: Centre for Addiction and Mental Health; 1999.
18. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:849-863.
19. Rey JM, Martin A, Krabman P. Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years. J Am Acad Child Adolesc Psychiatry 2004; 43:1194-1205.
20. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31:608-612.
21. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005; 57:1117-1127.
22. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370:319-328.
23. Anthony JC, Degenhardt L. Projecting the impact of changes in cannabis use upon schizophrenia in England and Wales: the role of assumptions and balance in framing an evidence-based cannabis policy. Addiction 2007; 102:515-516.
24. King RS, Mauer M. The war on marijuana: the transformation of the war on drugs in the 1990s. Harm Reduct J 2006; 3:6.
25. Senate Special Committee on Illegal Drugs. Discussion paper on cannabis. Ottawa: Canadian Senate, 2002.
26. MacCoun R, Reuter P. Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate. Science 1997; 278:47-52.
27. Kilmer B. Do cannabis possession laws influence cannabis use? In Spruit I (ed), Cannabis 2002 report: a joint international effort at the initiative of the Ministers of Public Health of Belgium, France, Germany, The Netherlands, Switzerland: technical report of the scientific conference Brussels, Belgium. Brussels: Ministry of Public Health, 2002. pp. 101-123.
28. Reinarman C, Cohen PD, Kaal HL. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health 2004; 94:836-842.
29. Korf DJ. Dutch coffee shops and trends in cannabis use. Addict Behav 2002; 27:851-866.
30. Saffer H, Chaloupka F. The demand for illicit drugs. NBER working paper no. 5238. Cambridge, MA: NBER, 1995.
31. Chaloupka FJ, Grossman M, Taurus J. The demand for cocaine and marijuana by youth. NBER working paper no. 6411. Cambridge, MA: NBER, 1998.
32. Pacula RL, Chriqui JF, King J. Decriminalization in the United States: what does it mean? NBER working paper no. 9690. Cambridge, MA: NBER, 2003.
33. Pacula RL. Does increasing the beer tax reduce marijuana consumption? J Health Econ 1998; 17:557-585.
34. McGeorge J, Aitken C. Effects of cannabis decriminalisation in the Australian Capital Territory on university student's pattern of use. J Drug Issues 1997; 27:785-793.
35. Donnelly N, Hall W, Christie P. Effects of the cannabis expiation notice scheme on levels and patterns of cannabis use in South Australia: evidence from the National Drug Strategy Houshold Surveys 1985-1995. National Drug Strategy Monograph series no. 37. Canberra: Australian Government, 1998.
36. Bammer G, Hall W, Wayne D, et al. Harm minimization in a prohibition context: Australia. Ann Am Acad Political Soc Sci 2002; 58:80-93.
37. Lenton S. Cannabis policy and the burden of proof. Is it now beyond reasonable doubt that cannabis prohibition is not working. Perth: National Drug Research Institute; 2000.
38. Cameron L, Williams J. Cannabis, alcohol and cigarettes: substitutes or compliments? Econ Rec 2001; 77:19-34.
39. Harrison LD, Backenheimer M, Inciardi JA. Cannabis use in the United States: implications for policy. Newark, DE: Center for Drug and Alcohol Studies University of Delaware, 1995.
40. Single E, Christie P, Ali R. The impact of cannabis decriminalisation in Australia and the United States. J Public Health Policy 2000; 21:157-186.
41. Maag V. Decriminalisation of cannabis use in Switzerland from an international perspective: European, American and Australian experiences. Int J Drug Policy 2003; 14:279-282.
42. DIMS. Drugs Information and Monitoring System: annual report 2006. Utrecht: Trimbos Institute, 2007.
43. Farelly MC, Bray JW, Zarkin GA et al. The effects of prices and policies on the demand for marijuana: evidence from the national Household Surveys on drug Abuse. NBER working paper no. 6940. Cambridge, MA: NBER, 1999.
44. May TH, Walburton H, Turnbull PJ, Hough M. Times they are a-changing: policing cannabis. York: Joseph Rowntree Foundation; 2002.
45. Health Committee. Inquiry into the public health strategies related to cannabis use and the most appropriate legal status. Presented to the New Zealand House of Representatives, 2003.
46. MacDonald D, Atkinson L. Social impacts of the legislative options for cannabis in Australia. Canberra: Australian Institute of Criminology; 1995.
47. Lenton S, Christi P, Humeniuk R et al. Infringment versus conviction: the social impact of a minor cannabis offence under a civil penalties system and strict prohibition in two Australian states. National Drug Strategy Monograph series no 36. Canberra: Australian Government, 1998.
48. Iguchi MY, London JA, Forge NG et al. Elements of well being affected by criminalizing the drug user. Public Health Rep 2002; Suppl 1:S146-S150.
49. Nolin PC, Kenny C. Cannabis: our position for a Canadian public policy. Report of the Senate Special Committee on Illegal Drugs. Ottawa: Canadian Senate, 2002.
50. Zimmer L, Morgan JP. Marijuana myths: marijuana facts. New York: Lindesmith Center; 1997.
51. Gray JD. The problem of consent in emergency medicine research. Can J Emerg Med 2001; 3:213-218.
52. MacLeod J, Hickman M, Vickerman P, et al. Response to commentaries. Addiction 2007; 102:516-518.